2500-g Low Birth Weight Cutoff: History and Implications for Future Research and Policy

Michelle M Hughes1, Robert E Black2, Joanne Katz2

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD, 21205, USA. Michelle.hughes@jhu.edu.

Insights

The 2500g low birth weight cutoff, historically used, is being re-evaluated. Research now distinguishes between preterm birth and intrauterine growth restriction to better identify high-risk newborns.

Area of Science:

  • Perinatal Medicine
  • Neonatology
  • Public Health Policy

Background:

  • Historically, prematurity, primarily assessed by birth weight, was linked to increased infant health risks.
  • The World Health Organization initially defined prematurity using a birth weight threshold of 2500 grams.
  • Research in the 1960s differentiated gestational age from birth weight, questioning the direct causal role of weight in health outcomes.

Purpose of the Study:

  • To investigate the historical origins of the 2500g low birth weight (LBW) cutoff.
  • To examine the evolution of indicators for identifying newborns at high risk of mortality.
  • To understand the shift in focus from LBW as a general indicator to specific etiologies.

Main Methods:

  • Historical literature review of perinatal research and definitions.
  • Analysis of the evolution of infant mortality risk assessment criteria.
  • Examination of the distinction between preterm birth and intrauterine growth restriction (IUGR).

Main Results:

  • The 2500g cutoff for LBW, though historically significant, remains a standard policy definition.
  • Low birth weight is now understood to stem from two distinct pathways: preterm birth and IUGR.
  • These pathways have different causal mechanisms for morbidity and mortality.

Conclusions:

  • While the 2500g LBW cutoff persists, current research emphasizes preterm birth and IUGR for accurate risk assessment.
  • Distinguishing between these etiologies allows for more targeted and effective interventions.
  • Focusing on direct causes of mortality, rather than LBW as a surrogate, improves understanding and outcomes.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
20.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520